MRES Plans U.S Road Show in January 2011.

BASEL, Switzerland, Nov. 29 /PRNewswire/ - BASEL, Switzerland, Nov. 29 / CNW Telbec / Neuro-Biotech Corp. (PINKSHEET: MRES) (OTCQB: MRES) is pleased to announce that it has begun the planning and scheduling of a road show for the Company which is intended to introduce the company to prospective shareholders in the United States.

The Company believes that the timing is right given that a financing is scheduled to close before year end. A completed financing combined with a clearer picture of the timeline to commercialization, on their varied products, will enable MRES management to better represent their potential upside to the Investment Community.  The trip will be focused on NANOCAP Investment Funds in New York, Boston, and Los Angeles. 

M. Claude Poulin md, CEO of MRES, was quoted as saying,   The Company has a clear understanding of what is required and expected in terms of delivering results.  The bar has been set high and it is our expectation that we will be able to meet our targets in regards to financing and relevant business development opportunities.

The recent 180˚ change of direction, made by the large pharmaceutical companies, have motivated management to commence a well planned strategic "Road Show" in early beginning of the year 2011.

For more information, do not hesitate to contact us by using the contact form on our corporate website at neuro-biotechcorp.com. Your request will be transferred to the appropriate persons and we will get back to you as soon as possible.

SOURCE Neuro-Biotech Corp.